我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 乌尔里希的期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 日内瓦医学教育与研究基金会
  • ICMJE
分享此页面

抽象的

Neurological Symptoms of Zika Virus Infection at Birth

Fresterio de Camelio

Objective: In 2015, it was noticed an ascent in the quantity of micro cephalic infants related with a background marked by nonspecific febrile affliction and rash during pregnancy in Brazil. Since then, microcephaly has become a major concern for public health. The connection between the Zika virus and congenital microcephaly was discovered a few months later. A brand-new TORCH member, the arbovirus Zika infects the developing brain, disrupts synaptogenesis, and causes other lesions of the central nervous system. It causes congenital infection through vertical transmission. The objective of this article is to report the Congenital Zika Syndrome (CZS) and to emphasize the importance of following up with affected children to better understand the evolutionary history of this new agent, optimize healthcare delivery, and enhance patient well-being.

Methods: To characterize the congenital Zika syndrome and recommend the systematization of some examinations and procedures for evaluating children exposed to ZIKV with or without microcephaly, based on the author's own experience, we conducted a review of the most pertinent literature regarding clinical manifestations and neuroimaging findings related to neurotropism of the Zika virus.

Conclusions: Vertical ZIKV infection can result in a wide range of neurological symptoms that go beyond microcephaly. Even children who do not have microcephaly should be monitored during their first few years of life because infection can cause neuropsicomotor delay, epilepsy, and visual abnormalities or be asymptomatic. The objective of the appropriate prospective multidisciplinary follow-up of these patients is to comprehend the natural history of this new agent and to improve their development and quality of life for themselves and their families.